CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 2, Pages -
Publisher
Springer Nature
Online
2019-01-25
DOI
10.1038/s41419-019-1306-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines
- (2017) Dae Wook Hwang et al. PANCREAS
- Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer
- (2017) Zebiao Ma et al. PLoS One
- Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP
- (2017) Philip Sander et al. Oncotarget
- Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer
- (2017) Maria Victoria Recouvreux et al. Frontiers in Endocrinology
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
- (2016) Daniel J Klionsky et al. Autophagy
- Inhibition of mTOR signaling protects photoreceptor cells against serum deprivation by reducing oxidative stress and inducing G2/M cell cycle arrest
- (2016) BIN FAN et al. Molecular Medicine Reports
- Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo
- (2016) Lijun Wang et al. TUMOR BIOLOGY
- Rheb promotes cancer cell survival through p27Kip1-dependent activation of autophagy
- (2015) Tania Campos et al. MOLECULAR CARCINOGENESIS
- Regulation of mTORC1 by PI3K signaling
- (2015) Christian C. Dibble et al. TRENDS IN CELL BIOLOGY
- High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer
- (2015) Zuli Yang et al. Clinics and Research in Hepatology and Gastroenterology
- Colon cancer cell invasion is promoted by protein kinase CK2 through increase of endothelin-converting enzyme-1c protein stability
- (2015) Ignacio Niechi et al. Oncotarget
- Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB
- (2015) Cristina Girardi et al. Biomed Research International
- Non-apoptotic cell death associated with perturbations of macropinocytosis
- (2015) William A. Maltese et al. Frontiers in Physiology
- mTOR pathway in colorectal cancer: an update
- (2015) Maria Giovanna Francipane et al. Oncotarget
- Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells
- (2015) G.Kenneth Gray et al. Oncotarget
- Methuosis
- (2014) William A. Maltese et al. AMERICAN JOURNAL OF PATHOLOGY
- Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations
- (2014) M Moschetta et al. BRITISH JOURNAL OF PHARMACOLOGY
- Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome
- (2014) Suchithra Menon et al. CELL
- Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells
- (2014) Ajda Coker-Gurkan et al. EXPERIMENTAL CELL RESEARCH
- mTOR and autophagy: A dynamic relationship governed by nutrients and energy
- (2014) E.A. Dunlop et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Autophagy regulation by nutrient signaling
- (2013) Ryan C Russell et al. CELL RESEARCH
- Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma
- (2013) Y. Zheng et al. CLINICAL CANCER RESEARCH
- Restoration of PTEN activity decreases metastases in an orthotopic model of colon cancer
- (2013) Sanjib Chowdhury et al. JOURNAL OF SURGICAL RESEARCH
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers
- (2013) Dustin A. Deming et al. PLoS One
- Epigenetic and genetic features of 24 colon cancer cell lines
- (2013) D Ahmed et al. Oncogenesis
- Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells
- (2012) Joshua Bliesath et al. CANCER LETTERS
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- The mTOR Signalling Pathway in Human Cancer
- (2012) Helena Pópulo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells
- (2012) BIRGITTE B. OLSEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
- (2011) Giovanni Ligresti et al. CELL CYCLE
- Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production
- (2011) Roger Yefi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CK2 functionally interacts with AKT/PKB to promote the β-catenin-dependent expression of survivin and enhance cell survival
- (2011) Daniela P. Ponce et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells
- (2011) Jean H Overmeyer et al. Molecular Cancer
- Serine 403 Phosphorylation of p62/SQSTM1 Regulates Selective Autophagic Clearance of Ubiquitinated Proteins
- (2011) Gen Matsumoto et al. MOLECULAR CELL
- Overexpression of Nuclear Protein Kinase CK2 α Catalytic Subunit (CK2α) as a Poor Prognosticator in Human Colorectal Cancer
- (2011) Kai-Yuan Lin et al. PLoS One
- Overexpression of Nuclear Protein Kinase CK2 β Subunit and Prognosis in Human Gastric Carcinoma
- (2010) Kai-Yuan Lin et al. ANNALS OF SURGICAL ONCOLOGY
- Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells
- (2010) Jan N Kreutzer et al. BMC CANCER
- mTOR regulation of autophagy
- (2010) Chang Hwa Jung et al. FEBS LETTERS
- Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of β-catenin transcriptional activity
- (2010) Daniela P. Ponce et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
- (2010) Sara M. Johnson et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Mitotic Raptor Promotes mTORC1 Activity, G2/M Cell Cycle Progression, and Internal Ribosome Entry Site-Mediated mRNA Translation
- (2010) F. Ramirez-Valle et al. MOLECULAR AND CELLULAR BIOLOGY
- Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
- (2009) Maria Ruzzene et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Protein Kinase CK2 in Health and Disease
- (2009) L. A. Pinna et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Protein Kinase CK2 in Health and Disease
- (2009) N. A. St-Denis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis
- (2008) J. H. Overmeyer et al. MOLECULAR CANCER RESEARCH
- Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc 716 mice
- (2008) T. Fujishita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search